Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19186
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPham, D-
dc.contributor.authorHardcastle, N-
dc.contributor.authorForoudi, Farshad-
dc.contributor.authorKron, T-
dc.contributor.authorBressel, M-
dc.contributor.authorHilder, B-
dc.contributor.authorChesson, B-
dc.contributor.authorOates, R-
dc.contributor.authorMontgomery, R-
dc.contributor.authorBall, D-
dc.contributor.authorSiva, S-
dc.date2016-04-23-
dc.date.accessioned2018-09-13T00:21:10Z-
dc.date.available2018-09-13T00:21:10Z-
dc.date.issued2016-09-
dc.identifier.citationClinical oncology 2016; 28(9): e101-108-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/19186-
dc.description.abstractIn technically advanced multicentre clinical trials, participating centres can benefit from a credentialing programme before participating in the trial. Education of staff in participating centres is an important aspect of a successful clinical trial. In the multicentre study of fractionated versus single fraction stereotactic ablative body radiotherapy in lung oligometastases (TROG 13.01), knowledge transfer of stereotactic ablative body radiotherapy techniques to the local multidisciplinary team is intended as part of the credentialing process. In this study, a web-based learning platform was developed to provide education and training for the multidisciplinary trial teams at geographically distinct sites. A web-based platform using eLearning software consisting of seven training modules was developed. These modules were based on extracranial stereotactic theory covering the following discrete modules: Clinical background; Planning technique and evaluation; Planning optimisation; Four-dimensional computed tomography simulation; Patient-specific quality assurance; Cone beam computed tomography and image guidance; Contouring organs at risk. Radiation oncologists, medical physicists and radiation therapists from hospitals in Australia and New Zealand were invited to participate in this study. Each discipline was enrolled into a subset of modules (core modules) and was evaluated before and after completing each module. The effectiveness of the eLearning training will be evaluated based on (i) knowledge retention after participation in the web-based training and (ii) confidence evaluation after participation in the training. Evaluation consisted of a knowledge test and confidence evaluation using a Likert scale. In total, 130 participants were enrolled into the eLearning programme: 81 radiation therapists (62.3%), 27 medical physicists (20.8%) and 22 radiation oncologists (16.9%). There was an average absolute improvement of 14% in test score (P < 0.001) after learning. This score improvement compared with initial testing was also observed in the long-term testing (>4 weeks) after completing the modules (P < 0.001). For most there was significant increase in confidence (P < 0.001) after completing all the modules.-
dc.language.isoeng-
dc.subjectClinical Trials-
dc.subjecteLearning-
dc.subjectimage-guided radiotherapy-
dc.subjectstereotactic radiotherapy-
dc.titleA Multidisciplinary Evaluation of a Web-based eLearning Training Programme for SAFRON II (TROG 13.01): a Multicentre Randomised Study of Stereotactic Radiotherapy for Lung Metastases.-
dc.typeJournal Articleen_US
dc.identifier.journaltitleClinical oncology-
dc.identifier.affiliationDepartment of Radiation Oncology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australiaen
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Radiation Oncology, Royal North Shore Hospital, Sydney, Australiaen
dc.identifier.affiliationDivision of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Radiation Oncology, WP Holman Clinic, Hobart, Australiaen
dc.identifier.affiliationDepartment of Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Medical Imaging and Health Sciences, Monash University, Melbourne, Australiaen
dc.identifier.affiliationSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australiaen
dc.identifier.affiliationTrans-Tasman Radiation Oncology Group, Newcastle, Australiaen
dc.identifier.affiliationDepartment of Radiotherapy Services, Peter MacCallum Cancer Centre, Melbourne, Australiaen
dc.identifier.doi10.1016/j.clon.2016.03.005-
dc.type.contentTexten_US
dc.identifier.orcid0000-0001-8387-0965-
dc.identifier.pubmedid27116931-
dc.type.austinJournal Article-
dc.type.austinMulticenter Study-
dc.type.austinRandomized Controlled Trial-
dc.type.austinResearch Support, Non-U.S. Gov't-
local.name.researcherForoudi, Farshad
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptRadiation Oncology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

30
checked on Nov 18, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.